PCRX - Pacira wins FDA approval for two new indications of Exparel
2023-11-10 09:06:08 ET
More on Pacira BioSciences
- Pacira BioSciences, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Pacira BioSciences, Inc. (PCRX) Q3 2023 Earnings Call Transcript
- Pacira BioSciences: Preparing For A Pivotal Q3 Earnings
- Pacira BioSciences Non-GAAP EPS of $0.72 misses by $0.06, revenue of $163.93M misses by $9M
- Pacira BioSciences Q3 2023 Earnings Preview
For further details see:
Pacira wins FDA approval for two new indications of Exparel